Amid falling birth rates in the U.S. and rising demand for IVF, Nucleus Genomics has launched Nucleus Embryo—the first genetic optimization software that allows prospective parents to access comprehensive genetic profiles of their embryos. This innovative tool offers unprecedented insights beyond basic viability, enabling informed decisions in embryo selection.
"Before there's a heartbeat, there's DNA," said Kian Sadeghi, Founder and CEO of Nucleus Genomics. "A single DNA file can reveal more about a baby's future than any medical test at this stage. While most clinics focus on whether an embryo will develop, many parents want more transparency and data. Nucleus Embryo empowers them with that ownership."
The software analyzes up to 20 embryos across 900+ hereditary conditions and 40 additional traits, including risks for cancers, chronic diseases, cognitive abilities, appearance, and mental health. The aim is to provide a more comprehensive understanding of each embryo’s long-term health potential.
To broaden access, Nucleus has partnered with Genomic Prediction, a pioneer in genome-wide embryo screening. This collaboration continues Genomic Prediction's commitment to helping parents select embryos with the highest health potential. Their screening focuses on identifying risks for hereditary and chronic diseases—acting as a proactive step in disease prevention.
Kelly Ketterson, CEO of Genomic Prediction, emphasized, “This partnership reflects our commitment to patient rights and expanding access to advanced scientific tools. Nucleus Embryo responds to what many of our patients have long requested—deeper insight into their future child’s health.”
Research indicates strong public support for such technologies. Many Americans are open to using genetic information for embryo selection based on health and cognitive traits. With IVF often requiring multiple cycles—each costing up to $25,000—having more detailed genetic data can improve success rates and reduce emotional and financial strain.
Nucleus Embryo represents a shift toward integrating advanced genetic insights into reproductive medicine. By offering a detailed understanding of an embryo’s potential for health and longevity, the platform aligns with broader efforts to optimize well-being from the very beginning of life.